Proactive Disclosure

Disclosure of Travel and Hospitality Expenses

Dr. Brien Benoit, Chairperson and CEO

Travel Expenses - June 2, 2009 to September 1, 2009

Date(s)	Purpose	Total Cost
6/3/2009 to 6/3/2009	Pre-hearing conference in the matter of Amgen Canada Inc. and the patented drug product Neulasta	$4.68
6/10/2009 to 6/10/2009	Attendance at the PMPRB to review presentation for the Drug Pricing & Reimbursement conference	$4.68
6/15/2009 to 6/17/2009	Presentation at the Drug Pricing & Reimbursement conference, Toronto	$1,011.93
7/8/2009 to 7/10/2009	Hearing in the matter of ratiopharm Inc. and the patented drug product ratio-Salbutamol	$14.04
	Total:	$1,035.33

Hospitality Expenses - June 2, 2009 to September 1, 2009

There are no hospitality expenses for this period.